1. MARKETS
  2. SECTOR : BANKING AND FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. ENGENE HOLDINGS INC

enGene Holdings Inc

XNAS: ENGN

Download real time

4.60 -0.27 (-5.54%)

New 52W Low in past week

60 XNAS Volume

XNAS 28 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
5S
13W
5O
0T
234.5

Market Cap

Below industry Median
-3.4

PE TTM

Negative PE TTM
-0.1

PEG TTM

PEG TTM is negative
0.9

Price to Book

Below industry Median
0.1

Beta 1Year

Very Low volatility


Insider Trading disclosures for enGene Holdings Inc

The latest disclosure was made by Raj Som Pruthi in enGene Holdings Inc where a trade of 280,000 Stock Option (Right to Buy) done was reported to US exchanges on Jan. 29, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Raj Som Pruthi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 280,000 280,000 - - Stock Option (Right to Buy)
Ryan Daws Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 280,000 280,000 - - Stock Option (Right to Buy)
Ronald H.W. Cooper Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 850,000 850,000 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 250,000 250,000 - - Stock Option (Right to Buy)
Alexander Julian Nichols Chief Strategy & Ops. Ofc Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 250,000 250,000 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 100,000 100,000 - - Stock Option (Right to Buy)
Joan Connolly Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 210,000 210,000 - - Stock Option (Right to Buy)
Ronald H.W. Cooper Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.70 per share. 27 Sep 2024 10,000 10,000 - 5.7 57,000 Common Shares
Raj Som Pruthi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2024 110,000 110,000 - - Stock Option (Right to Buy)
Ronald H.W. Cooper Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jul 2024 1,250,000 1,250,000 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2024 20,000 20,000 - - Stock Option (Right to Buy)
Wouter Joustra Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2024 40,000 40,000 - - Stock Option (Right to Buy)
Jasper Bos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2024 20,000 20,000 - - Stock Option (Right to Buy)
Paul J. Hastings Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2024 40,000 40,000 - - Stock Option (Right to Buy)
Lota S. Zoth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2024 20,000 20,000 - - Stock Option (Right to Buy)
Richard M. Glickman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 May 2024 120 0 - - Stock Option (Right to Buy)
Richard M. Glickman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.89 per share. 28 May 2024 120 24,675 - 0.9 107 Common Shares
Lota S. Zoth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2024 40,000 40,000 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2024 52,940 0 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.89 per share. 18 Mar 2024 52,940 102,873 - 0.9 47,117 Common Shares
Richard P. Bryce Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2023 153,000 153,000 - - Stock Option (Right to Buy)
Ryan Daws Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2023 232,000 232,000 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 52,940 52,940 - - Stock Option (Right to Buy)
Jason D. Hanson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 524,544 524,544 - - Stock Option (Right to Buy)
Jason D. Hanson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 512,826 512,826 - - Stock Option (Right to Buy)
Jason D. Hanson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 10,906 10,906 - - Stock Option (Right to Buy)
Jason D. Hanson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 30,939 30,939 - - Stock Option (Right to Buy)
Jason D. Hanson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 137,051 137,051 - - Stock Option (Right to Buy)
James Crowley Sullivan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 88,901 88,901 - - Stock Option (Right to Buy)
James Crowley Sullivan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 118,509 118,509 - - Stock Option (Right to Buy)
Alexander Julian Nichols Pres. & Chief Operating Ofc. Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 177,935 177,935 - - Stock Option (Right to Buy)
Alexander Julian Nichols Pres. & Chief Operating Ofc. Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 101,924 101,924 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 1,266 1,266 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 22,860 22,860 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 28,876 28,876 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 49,933 49,933 - - Common Shares
Anthony Tzeyew Cheung Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 185,222 185,222 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 2,255 2,255 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 155,472 155,472 - - Stock Option (Right to Buy)
Anthony Tzeyew Cheung Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 36,618 36,618 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 4,123 4,123 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 12,032 12,032 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 14,205 14,205 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 12,001 12,001 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 11,189 11,189 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 120 120 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 24,555 24,555 - - Common Shares
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 9,023 9,023 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 3,188 3,188 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters